TIM-3 Alzheimer's therapy represents a groundbreaking approach in the fight against Alzheimer's disease, leveraging insights from the immune system to tackle the challenges posed by this neurodegenerative disorder.Recent studies suggest that targeting the TIM-3 checkpoint molecule, which inhibits microglia—the brain's immune cells—could enhance their ability to clear amyloid plaques, a hallmark of Alzheimer's.